Show Search Form
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | Human Embryo Experiments | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), what specific recommendations the Human Fertilisation and Embryology Authority has made in order to resolve any conflict between the demands of research and the best interests of patients, in particular regarding (1) a demand for sufficient numbers of human embryos at the single-celled zygote stage in order successfully to perform genome editing by means of CRISPR-Cas9, and (2) the usual practice of transferring embryos to the uterus after assessing their potential to develop further after either two to three days or five to six days. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5909 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | Human Embryo Experiments | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), whether the recently approved application by the Human Fertilisation and Embryology Authority to perform genome editing in human embryos by means of CRISPR-Cas9 will be performed on embryos specifically created for research or only on those considered to be surplus to infertility treatments; whether that research application included any application for the creation of embryos; and if not, why the person responsible requested that reference to surplus embryos should be removed from the research project title. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5910 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | Human Embryo Experiments | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), what evidence the Human Fertilisation and Embryology Authority has received that a major cause of miscarriage is the failure of embryos to develop to the blastocyst stage; what records they hold regarding miscarriages occurring after human embryos that were known to be unable to develop further in vitro had been deliberately transferred to the uterus of a patient; and what sanctions are imposed on clinics in which such implantations take place. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5911 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|